Today’s news
Guardant Health, Harris Poll Survey Shows 92% of Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered
Survey highlights strong support for expanded access to innovative blood-based colorectal cancer screening options like Guardant's FDA-approved Shield test.
Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
The partnership expands access to Shield, the first and only FDA-approved blood test for colorectal cancer screening in average-risk adults.
Leading Acute Myeloid Leukemia Expert Named Dylan Burke Endowed Chair in Immunotherapy
Dr. Soheil Meshinchi recognized for his work in developing novel treatments for AML
